POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients
Journal of The International Aids Society（2008）
关键词
Ritonavir, Virological Response, Darunavir, Enfuvirtide, Background Regimen
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要